1-4 of 4
Finlay Macrae
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cancer Prevention with Resistant Starch in Lynch Syndrome Patients in the CAPP2-Randomized Placebo Controlled Trial: Planned 10-Year Follow-up

John C. Mathers, Faye Elliott, Finlay Macrae, Jukka-Pekka Mecklin, Gabriela Möslein, Fiona E. McRonald, Lucio Bertario, D. Gareth Evans, Anne-Marie Gerdes, Judy W.C. Ho, Annika Lindblom, Patrick J. Morrison, Jem Rashbass, Raj S. Ramesar, Toni T. Seppälä, Huw J.W. Thomas, Harsh J. Sheth, Kirsi Pylvänäinen, Lynn Reed, Gillian M. Borthwick, D. Timothy Bishop, John Burn, on behalf of the CAPP2 Investigators
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2022) 15 (9): 623–634.
https://doi.org/10.1158/1940-6207.CAPR-22-0044
Published: 01 September 2022
View articletitled, Cancer Prevention with Resistant Starch in Lynch Syndrome Patients in the CAPP2-Randomized Placebo Controlled Trial: Planned 10-Year Follow-up
Open the PDF for Cancer Prevention with Resistant Starch in Lynch Syndrome Patients in the CAPP2-Randomized Placebo Controlled Trial: Planned 10-Year Follow-up in another window
Includes: Supplementary data
Journal Articles

Incident Cancer Risk and Signatures Among Older MUTYH Carriers: Analysis of Population-Based and Genomic Cohorts

Jonathan M. Downie, Moeen Riaz, Jing Xie, Minyi Lee, Andrew T. Chan, Peter Gibbs, Suzanne G. Orchard, Suzanne E. Mahady, Robert P. Sebra, Anne M. Murray, Finlay Macrae, Eric Schadt, Robyn L. Woods, John J. McNeil, Paul Lacaze, Manish Gala
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2022) 15 (8): 509–519.
https://doi.org/10.1158/1940-6207.CAPR-22-0080
Published: 01 August 2022
View articletitled, Incident Cancer Risk and Signatures Among Older MUTYH Carriers: Analysis of Population-Based and Genomic Cohorts
Open the PDF for Incident Cancer Risk and Signatures Among Older MUTYH Carriers: Analysis of Population-Based and Genomic Cohorts in another window
Includes: Supplementary data
Journal Articles

Aspirin and the Risk of Colorectal Cancer According to Genetic Susceptibility among Older Individuals

Andrew Bakshi, Yin Cao, Suzanne G. Orchard, Prudence R. Carr, Amit D. Joshi, Alisa K. Manning, Daniel D. Buchanan, Asad Umar, Ingrid M. Winship, Peter Gibbs, John R. Zalcberg, Finlay Macrae, John J. McNeil, Paul Lacaze, Andrew T. Chan
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2022) 15 (7): 447–454.
https://doi.org/10.1158/1940-6207.CAPR-22-0011
Published: 05 July 2022
View articletitled, Aspirin and the Risk of Colorectal Cancer According to Genetic Susceptibility among Older Individuals
Open the PDF for Aspirin and the Risk of Colorectal Cancer According to Genetic Susceptibility among Older Individuals in another window
Includes: Supplementary data
Journal Articles

Five-Year Efficacy and Safety Analysis of the Adenoma Prevention with Celecoxib Trial

Monica M. Bertagnolli, Craig J. Eagle, Ann G. Zauber, Mark Redston, Aurora Breazna, KyungMann Kim, Jie Tang, Rebecca B. Rosenstein, Asad Umar, Donya Bagheri, Neal T. Collins, John Burn, Daniel C. Chung, Thomas Dewar, T. Raymond Foley, Neville Hoffman, Finlay Macrae, Ronald E. Pruitt, John R. Saltzman, Bruce Salzberg, Thomas Sylwestrowicz, Ernest T. Hawk, for the Adenoma Prevention with Celecoxib Study Investigators
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2009) 2 (4): 310–321.
https://doi.org/10.1158/1940-6207.CAPR-08-0206
Published: 06 April 2009
View articletitled, Five-Year Efficacy and Safety Analysis of the Adenoma Prevention with Celecoxib Trial
Open the PDF for Five-Year Efficacy and Safety Analysis of the Adenoma Prevention with Celecoxib Trial in another window
Includes: Supplementary data